Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Pulmonary Embolism

• RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
• The PEERLESS II Study
• 129Xe MRI Cardiopulmonary
• Supplemental Oxygen in Pulmonary Embolism (SO-PE)
• Comparison of Two Pulmonary Embolism Treatments
• Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy
• Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events
• Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism
• Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial
• Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE
• A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
• A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
• Effect of iNO in Patients With Submassive and Massive PE
• Inhaled Nitric Oxide (iNO) in Post-Pulmonary Embolism (Post-PE)
• Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
• Pre- vs Postoperative Thromboprophylaxis for Liver Resection
• STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism
• Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer
• Recombinant Non-immunogenic Staphylokinase VS Alteplase for Massive PE a Randomized Non-inferiority Trial
• Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism
• Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection
• Postoperative Thrombosis Prevention in Patients With CD
• Pulmonary Embolism International THrOmbolysis Study-3
• Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19
• Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19
• Sildenafil in Acute Pulmonary Embolism
• Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
• tPA by Endovascular Administration for the Treatment of Submassive PE Using CDT for the Reduction of Thrombus Burden
• Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy
• Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism
• Injection of Recombinant Human Tissue-type Plasminogen Activator Derivative for Acute Pulmonary Embolism(rPA)
• Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism
• PET Fibrin Imaging of DVT and PE
• Air Versus Oxygen for Intermediate-Risk Pulmonary Embolism (AIRE)
• Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism
• Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study
• Thrombolysis Endovascular Treatment of Pulmonary Embolism
• Screening for Cancer in Patients With Thromboembolic Disease
• Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease
• First - In - Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism
• Chemoprophylaxis Plus Early Ambulation
• Low Dose Catheter Directed Thrombolysis for Acute Pulmonary Embolism
• Catheter Directed Interventions in Pulmonary Embolism
• Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE
• Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin
• Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma
• DS-9231 in Intermediate-risk (Sub-massive) Acute Pulmonary Embolism (PE)
• A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism
• Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery
• The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism
• Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography
• The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)
• A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism
• Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
• Outcomes Study in Patients Receiving Aspirin With Mechanical Compression Devices Versus Aspirin Alone Following Knee and Hip Arthroplasty
• PREvention of VENous ThromboEmbolism Following Radical Prostatectomy
• Pradaxa or Warfarin for Prevention of Recurrent VTE in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation and Thrombolytic Therapy
• Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin
• Sidlenafil in Combination With Oral Anticoagulants in Patients With Intermediate-high Risk of Pulmonary Embolism
• Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism
• Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
• Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
• A Different Approach to Preventing Thrombosis
• Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
• Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
• A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer
• Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose
• Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients
• Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients
• Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism
• Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial
• Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for Acute Intermediate-Risk Pulmonary Embolism.
• Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
• A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department
• Diuretic Vascular Filling in the Initial Management of Acute PE With Right Ventricular Dysfunction Normotensive
• XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis
• NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial
• Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
• : Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)
• Enoxaparin Metabolism in Reconstructive Surgery Patients
• Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico
• Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
• Diuretic Versus Placebo in Pulmonary Embolism
• Use of Gadolinium in CT Pulmonary Angiography
• Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
• Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation
• Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism
• Laparoscopic Bariatric Surgery: Two Regimens of Venous Thromboprophylaxis: Prospective Randomized Study
• Cancer Venous Thromboembolism (VTE)
• Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis
• Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification
• Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)
• Low Dose Prolonged Infusion of Tissue Type Plasminogen Activator Therapy in Massive Pulmonary Embolism
• Comparison of Low-Molecular-Weight Heparin (LMWH) and Unfractionated Heparin (UFH) in Combination With Thrombolytic Treatment of Acute Massive Pulmonary Thromboembolism
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)
• Nitric Oxide to Treat Pulmonary Embolism
• Efficacy of Low (30ml) Versus Full Dose (100ml) Contrast CT Pulmonary Angiography in Detecting Emboli
• The Study of Warfarin Maintenance Dose in Chinese Patients
• Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
• Anticoagulation Length in Cancer Associated Thrombosis
• AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
• Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
• Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
• Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries
• Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis
• Diclofenac for Submassive PE
• Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation
• Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy
• Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD
• Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) Patients
• Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy
• Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism
• Study Of Lybrel In Relation To Venous Thromboembolism
• Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis
• ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism
• Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar)
• Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis
• Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
• Drug Interaction Between Paracetamol and Warfarin
• Epoprostenol in Pulmonary Embolism
• Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).
• The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
• VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
• Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC)
• Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer
• Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients
• Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures
• A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
• Phase I Trial of Inhaled Nitric Oxide to Treat Acute Pulmonary Embolism
• 12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China
• Nadroparin for the Initial Treatment of Pulmonary Thromboembolism
• Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
• Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in China
• Prophylaxis Against DVTs After Primary Hip and Knee Replacement Surgery
• Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study.
• Tinzaparin in the Treatment of the Acute Pulmonary Embolism
• Clot Dissolving Treatment for Blood Clots in the Lungs
• Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
• PEITHO Pulmonary Embolism Thrombolysis Study
• Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
• Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid
• Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon
• Inhaled Nitric Oxide in Pulmonary Embolism
• Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing
• Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients
• Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
• Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
• Post-marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary Embolism
• Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study
• Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study
• Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers
• Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)
• Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism
• Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism
• Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information
• Deferment of Imaging for Pulmonary Embolism
• Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy
• Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
• 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE
• Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)
• Detection of Pulmonary Embolism With CECT
• Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach
• A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"
• A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer
• VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis
• D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism
• Odiparcil For The Prevention Of Venous Thromboembolism
• Aspirin for the Prevention of Recurrent Venous Thromboembolism
• Tenecteplase Pulmonary Embolism Italian Study
• Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study
• The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial
• Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure
• Fixed Dose Heparin Study
• Genetic Determinants of Warfarin Anticoagulation Effect
• BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery
• SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis
• SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism